![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abstract of clinical data accepted for poster presentation at ESMO Congress 2024 in SeptemberESMO poster to include protocol-defined TAMARACK Phase 2 mCRPC study data, including pre-defined...
ROCKVILLE, MD, July 30, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 1.35 | 0.710152551289 | 190.1 | 191.45 | 187.4 | 14 | 188.64583333 | DE |
12 | 10.95 | 6.06648199446 | 180.5 | 192.55 | 179.2 | 23 | 185.24927536 | DE |
26 | 4.75 | 2.54418853776 | 186.7 | 192.8 | 179.2 | 27 | 187.56562914 | DE |
52 | 18.75 | 10.8569774175 | 172.7 | 192.8 | 156.1 | 49 | 179.70563504 | DE |
156 | 48.7 | 34.11558669 | 142.75 | 192.8 | 137.15 | 65 | 161.60851032 | DE |
260 | 63.45 | 49.5703125 | 128 | 192.8 | 95.5 | 79 | 149.23854072 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions